Interim report
Page 1
Lindab International AB ( publ ) Interim Report January - March 2021 Lindab continues to improve its operating margin During the first quarter , operating profit and operating margin continued to improve . Sales were in line with the previous year , adjusted for currency . The two largest business areas , Ventilation Systems and Profile Systems , showed organic sales growth . It is a sign of strength considering that the first quarter of last year was relatively unaffected by the pandemic . Cash flow from operating activities continues to improve . First quarter 2021 • Net sales decreased by 4 percent to SEK 2,248 m ( 2,332 ) . Organic growth was 0 percent while currency impacted net sales by -5 percent . • • Operating profit increased to SEK 193 m ( 184 ) . No one - off items or restructuring costs were reported . ⋅ Operating margin increased to 8.6 percent ( 7.9 ) . • Profit for the period increased to SEK 140 m ( 136 ) . • Earnings per share , before and after dilution , increased to SEK 1.83 ( 1.78 ) . • Cash flow from operating activities increased to SEK 60 m ( 26 ) . • Steel prices continued to increase during the quarter . Lindab has long - term purchasing agre- ements , creating strategic room for manoeuvre . Price adjustments to customers have been made at an early stage . • In March , Jonas Arkestad was appointed new Chief Financial Officer ( CFO ) . He will start his new position no later than September 2021 . Key Figures 2021 Jan - Mar 2020 Change , Jan - Mar % 2020 Jan - Dec Net sales , SEK m 2,248 2,332 -4 9,166 Adjusted operating profit , SEK m 193 184 Operating profit , SEK m 193 184 55 916 846 Adjusted¹ operating margin , % 8.6 7.9 10.0 Operating margin , % 8.6 7.9 9.2 Profit for the period , SEK m 140 136 3 596 Earnings per share , before and after dilution , SEK 1.83 1.78 3 7.80 Cash flow from operating activities , SEK m 60 26 131 1,129 1 ) Adjusted operating profit / operating margin does not include significant one - off items and restructuring costs . See ' Reconciliations ' page 19 . Lindab